Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday
digestive
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be